Listener Q&A: Drug Price Controls, EU Tariffs, and the August Recess | Making Medicine Podcast
In this week’s special Q&A episode, John Stanford tackles your biggest questions from around the biotech and policy world. From the growing list of drug price controls under the IRA to the newly announced 15% EU tariffs on medicines, there's a lot at stake for patients, companies, and innovation. John also breaks down the temporary NIH funding freeze, what it means for research, and why August recess matters more than you think.
What impact do you think drug price controls will have on innovation?
Should medicines be included in international tariff negotiations?
What policies should Congress…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.